Lataa...

Profile of omalizumab in the treatment of chronic spontaneous urticaria

Chronic spontaneous urticaria (CSU) is a disease with significant morbidity and relative prevalence that has important effects on the quality of life (QoL) of those who suffer from it. Omalizumab is a recombinant humanized anti-immunoglobulin E (IgE) antibody that binds to the Cε3 domain of the IgE...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drug Des Devel Ther
Päätekijät: Labrador-Horrillo, Moises, Ferrer, Marta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554406/
https://ncbi.nlm.nih.gov/pubmed/26346472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S56004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!